Share Your Research, Maximize Your Social Impacts
Therapy with mTOR Inhibitors in Polyomavirus Allograft Nephropathy (PVAN): A Five Year Follow Up
Journal: Archive of Organ Transplantation (Vol.2, No. 1)Publication Date: 2017-11-15
Authors : Ana Theresa Guanaes Bonini André Barros Albuquerque Esteves Leonardo Figueiredo Camargo Carla Feitosa do Valle Gabriel Giollo Rivelli Marcos Vinícius de Sousa; Marilda Mazzali;
Page : 001-003
Keywords : Polyomavirus; mTOR inhibitor; Renal transplantation;
Source : Download
Find it from : Google Scholar
Abstract
Polyomavirus nephropathy (PVAN) has a negative impact on renal allograft survival. Therapy options include reduction of immunosuppression and antiviral drugs.
Other Latest Articles
- The Impact of Hepatitis C Virus Infection on the Clinical Course, Short Term and Long–Term Outcome in Renal Transplant Recipients–A Prospective and Retrospective Study
- Split/Reduced Liver Transplantation “IMSS”: The First Two Cases and Literature Overview
- Recurrence of Immunotactoid Glomerulopathy with Monoclonal IgG3κ Deposits after Kidney Transplant
- Serotonin Receptors Mediate Contractile Activity of Rat’s Esophagus in-vivo
- Interpretation of Crossmatch reports in a patient with Lupus Nephritis
Last modified: 2019-01-08 19:25:51